Tag: dose selection

Preclinical Development and IND/CTA Readiness: making the candidate safe enough to test in people

This is Part 4 of The Drug Development Playbook. We talk about building nonclinical and CMC evidence that lets regulators say yes to first-in-human trials.

February 13, 2026